NCT00287170 Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00280956 Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease Status COMPLETED Phase PHASE4
NCT00278577 Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease Status TERMINATED Phase PHASE1
NCT00275418 Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease Status UNKNOWN Phase PHASE3
NCT00267722 Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease Status COMPLETED Phase PHASE2
NCT00267709 Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease Status COMPLETED Phase PHASE2
NCT00265772 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Status UNKNOWN Phase PHASE4
NCT00257699 Study of Antibiotics in the Treatment of Colonic Crohn's Disease Status TERMINATED Phase PHASE2
NCT00252369 Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment. Status TERMINATED Phase NA
NCT00250198 The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease Status COMPLETED Phase PHASE2
NCT00245505 The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" Status TERMINATED Phase PHASE3
NCT00234741 Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT00225810 A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease Status COMPLETED Phase PHASE4
NCT00224562 The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists Status UNKNOWN Phase N/A